参考文献
|
-
Abreu, J.G.,Ketpura, N.I.,Reversade, B.D.,Robertis, E.M.(2002).Connective-tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-β.Nat. Cell Biol.,4,599-604.
-
Aguiyi, J.C.,Obi, C.I.,Gang, S.S.,Igweh, A.C.(2000).Hypoglycaemic activity of Ocimum gratissimum in rats.Fitoterapia.,71,444-446.
-
Atal, C.K.,Sharma, M.L.,Kaul, A.,Khajuria, A.(1986).Immunomodulating agents of plant origin. I: Preliminary screening.J. Ethnopharmacol.,18,133-141.
-
Au, C.G.,Butler, T.L.,Sherwood, M.C.,Egan, J.R.,North, K.N.,Winlaw, D.S.(2011).Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.Int. J. Exp. Pathol.,92,57-65.
-
Ayisi, N.K.,Nyadedzor, C.(2003).Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections.Antiviral Res.,58,25-33.
-
Aziba, P.I.,Bass, D.,Elegbe, Y.(1999).Pharmacological investigation of Ocimum gratissimum in rodents.Phytother. Res.,13,427-429.
-
Beisvag, V.,Kemi, O.J.,Arbo, I.,Loennechen, J.P.,Wisløff, U.,Langaas, M.,Sandvik, A.K.,Ellingsen, Ø.(2009).Pathological and physiological hypertrophies are regulated by distinct gene programs.Eur. J. Prev. Cardiol.,16,690-697.
-
Bernardo, B.C.,Weeks, K.L.,Pretorius, L.,McMullen, J.R.(2010).Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.Pharmacol. Ther.,128,191-227.
-
Chaturvedi, P.,George, S.,John, A.(2007).Preventive and protective effects of wild basil in ethanol-induced liver toxicity in rats.Brit. J. Biomed. Sci.,64,10-12.
-
Chen, M.M.,Lam, A.,Abraham, J.A.,Schreiner, G.F.,Joly, A.H.(2000).CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.J. Mol. Cell. Cardiol.,32,1805-1819.
-
George, S.,Chaturvedi, P.(2009).A comparative study of the antioxidant properties of two different species of Ocimum of southern Africa on alcohol-induced oxidative stress.J. Med. Food,12,1154-1158.
-
Gould, L.,Shariff, M.,Zahir, M.,Di Lieto, M.(1969).Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop.J. Clin. Invest.,48,860-868.
-
Helmy, A.,Jalan, R.,Newby, D.E.,Hayes, P.C.,Webb, D.J.(2000).Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis.Gastroenterology,118,565-572.
-
Hernández-Muñoz, R.,Diáz-Muñoz, M.,Suárez-Cuenca, J.A.,Trejo-Solís, C.,López, V.,Sánchez-Sevilla, L.,Yañez, L.,de Sánchez, V.C.(2001).Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats.Hepatology,34,677-687.
-
Heymans, S.,Lupu, F.,Terclavers, S.,Vanwetswinkel, B.,Herbert, J.M.,Baker, A.,Collen, D.,Carmeliet, P.,Moons, L.(2005).Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.Am. J. Pathol.,166,15-25.
-
Ilori, M.,Sheteolu, A.O.,Omonigbehin, E.A.,Adeneye, A.A.(1996).Antidiarrhoeal activities of Ocimum gratissimum (Lamiaceae).J. Diarrhoeal Dis. Res.,14,283-285.
-
Kelbaek, H.,Eriksen, J.,Brynjolf, I.,Raboel, A.,Lund, J.O.,Munck, O.,Bonnevie, O.,Godtfredsen, J.(1984).Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver.Am. J. Cardiol.,54,852-856.
-
Khan, R.,Sheppard, R.(2006).Fibrosis in heart disease: understanding the role of transforming growth factor-β1 in cardiomyopathy, valvular disease and arrhythmia.Immunology,118,10-24.
-
Koitabashi, N.,Arai, M.,Kogure, S.,Niwano, K.,Watanabe, A.,Aoki, Y.,Maeno, T.,Nishida, T.,Kubota, S.,Takigwa, M.,Kurabayashi, M.(2007).Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.Hypertension,49,1120-1127.
-
Kong, S.W.,Bodyak, N.,Yue, P.,Liu, Z.,Brown, J.,Izumo, S.,Kang, P.M.(2005).Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats.Physiol. Genomics,21,34-42.
-
Kowalski, H.J.,Abelmann, W.H.(1953).The cardiac output at rest in Laennec's cirrhosis.J. Clin. Invest.,32,1025-1033.
-
Laemmli, U.K.(1970).Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature,227,680-685.
-
Lee, M.J.,Chen, H.M.,Tzang, B.S.,Lin, C.W.,Wang, C.J.,Liu, J.Y.,Kao, S.H.(2011).Ocimum gratissimum aqueous extract protects H9c2 Myocardiac Cells from H2O2-Induced Cell Apoptosis through Akt Signalling.Evid. Based Complement. Alternat. Med.,2011,578060.
-
Li, P.C.,Chiu, Y.W.,Lin, Y.M.,Day, C.H.,Pai, P.,Tsai, F.J.,Tsai, C.H.,Kuo, Y.C.,Chang, H.C.,Liu, J.Y.,Huang, C.Y.(2012).Herbal supplement ameliorates cardiac hypertrophy in rats with CCl4-induced liver cirrhosis.Evid. Based Complement. Alternat. Med.,2012,139045.
-
Lin, C.,Lin, J.,Chang, C.(1995).Evaluation of hepatoprotective effects of "Chhit-Chan-Than" from Taiwan.Pharm. Biol.,33,139-143.
-
Lin, C.C.,Tsai, C.C.,Yen, M.H.(1995).The evaluation of hepatoprotective effects of Taiwan folk medicine 'Teng-Khia-U'.J. Ethnopharmacol.,45,113-123.
-
Mann, D. L.(edited)(2004).Heart Failure: A Companion to Braunwald's Heart Disease.Philadelphia, USA:Saunders.
-
Marta, R.O.,Juan, R.V.,Elsa, S.L.,Gisselle, C.,Jesús, E.(2007).TGF-β signaling in vascular fibrosis.Cardiovasc. Res.,74,196-206.
-
Matsusaka, H.,Ide, T.,Matsushima, S.,Ikeuchi, M.,Kubota, T.,Sunagawa, K.,Kinugawa, S.,Tsutsui, H.(2006).Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.Hypertension,47,711-717.
-
McMullen, J.R.,Jennings, G.L.(2007).Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.Clin. Exp. Pharmacol. Physiol.,34,255-262.
-
Miner, E.C.,Miller, W.L.(2006).A look between the cardiomyocytes: the extracellular matrix in heart failure.Mayo Clin. Proc.,81,71-76.
-
Mourelle, M.,Muriel, P.,Favari, L.,Franco, T.(1989).Prevention of CCl4-induced liver cirrhosis by silymarin.Fundam. Clin. Pharmacol.,3,183-191.
-
Muriel, P.,Garciapiña, T.,Perez-Alvarez, V.,Mourelle, M.(1992).Silymarin protects against paracetamol-induced lipid peroxidation and liver damage.J. Appl. Toxicol.,12,439-442.
-
Muriel, P.,Mourelle, M.(1990).Prevention by silymarin of membrane alterations in acute CCl4 liver damage.J. Appl. Toxicol.,10,275-279.
-
Nangia-Makker, P.,Tait, L.,Shekhar, M.P.,Palomino, E.,Hogan, V.,Piechocki, M.P.,Funasaka, T.,Raz, A.(2007).Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum.Int. J. Cancer,121,884-894.
-
Onajobi, F.D.(1986).Smooth muscle contracting lipid-soluble principles in chromatographic fractions of Ocimum gratissimum.J. Ethnopharmacol.,18,3-11.
-
Rohini, A.,Agrawal, N.,Koyani, C.N.,Singh, R.(2010).Molecular targets and regulators of cardiac hypertrophy.Pharmacol. Res.,61,269-280.
-
Rosenkranz, S.(2004).TGF-β1 and angiotensin networking in cardiac remodeling.Cardiovasc. Res.,63,423-432.
-
Shi-Wen, X.,Leask, A.,Abraham, D.(2008).Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.Cytokine Growth Factor Rev.,19,133-144.
-
Skoumal, R.,Tóth, M.,Serpi, R.,Rys, J.,Leskinen, H.,Ulvila, J.,Saiho, T.,Aro, J.,Ruskoaho, H.,Szokodi, I.,Kerkel, R.(2011).Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity.J. Mol. Cell. Cardiol.,50,634-641.
-
Theocharidou, E.,Krag, A.,Bendtsen, F.,Moller, S.,Burroughs, A.K.(2012).Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis.Liver Int.,32,1327-1332.
-
Timoh, T.,Protano, M.A.,Wagman, G.,Bloom, M.,Vittorio, T.J.(2011).A perspective on cirrhotic cardiomyopathy.Transplant. Proc.,43,1649-1653.
-
Valenzuela, A.,Garrido, A.(1994).Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin.Biol. Res.,27,105-112.
-
Wang, X.,McLennan, S.V.,Allen, T.J.,Twigg, S.M.(2010).Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes.J. Cell Commun. Signal.,4,15-23.
-
Weng, Y.J.,Kuo, W.W.,Kuo, C.H.,Tung, K.C.,Tsai, C.H.,Lin, J.A.,Tsai, F.J.,Hsie, D.J.Y.,Huang, C.Y.,Hwang, J.M.(2010).BNIP3 induces IL6 and calcineurin/NFAT3 hypertrophic-related pathways in H9c2 cardiomyoblast cells.Mol. Cell. Biochem.,345,241-247.
|